Tags |
|
|
Links |
|
|
Digg It - MLM Code of Ethics
Despite the fact that the MLM business model has the potential to provide enormous benefits across many areas: financial, economic, social, educational and philosophical, it has largely failed to live up to it promise. In our view this is because in many cases the commission structure itself promotes greed and stupidity, there has been too much involvement by people with criminal intent, there has been an enormous lack of re
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
al business expertise, and there has been totally insufficient debate on principles and ethics.
In seeking to play some part in redressing this situation, the following code is compulsory for companies who wish to be listed as preferred MLM opportunities on our site. That is, no company will be listed as “recommended” without written commitment to this code and there will be no exceptions made for any reason.
In seeking to play some part in redressing this situation, the following code is compulsory for companies who wish to be listed as preferred MLM opportunities on our site. That is, no company will be listed as “recommended” without written commitment to this code and there will be no exceptions made for any reason.
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
There is no fee for listing, and no monies may be received for commission on product sales or recruitment as a result of such listing. However companies should be aware that their application for listing will be presented to objective 3rd parties such as the Better Business Bureau for comment and that listing cannot proceed when there is any significant unsettled legislative or litigation issue pending.
Application requires
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
the submission of the full names of founders, directors and majority shareholders and listing will not proceed where such persons have convictions for white collar or organised crime, or where there are or have been any known links with organised crime whatsoever.
CODE OF ETHICS
1 Our compensation plan is fully explained prior to recruitment, and remains transparent and accessible to all recruits and potentia
CODE OF ETHICS
1 Our compensation plan is fully explained prior to recruitment, and remains transparent and accessible to all recruits and potentia
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
recruits.
2 A net earnings statement is made available to our members at least annually, and this statement accurately records net earnings of all members, such that members are able to see for themselves what the true earnings are. (Earnings are calculated at commissions minus cost of product purchases, or any other purchase from the MLM company, such as training material, marketing material, etc.) The full intent
2 A net earnings statement is made available to our members at least annually, and this statement accurately records net earnings of all members, such that members are able to see for themselves what the true earnings are. (Earnings are calculated at commissions minus cost of product purchases, or any other purchase from the MLM company, such as training material, marketing material, etc.) The full intent
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
on of this statement is that existing and potential recruits can readily identify the true financial benefit, or otherwise, of joining this MLM company. The statement must be accompanied by certification by a qualified, 3rd party auditor. The earnings table will take the form of the following table:
x persons (X% of total A) earned >$580,000 (X% of total B)
x persons (X% of total A) earned >$300,000 (X% of total B
x persons (X% of total A) earned >$580,000 (X% of total B)
x persons (X% of total A) earned >$300,000 (X% of total B
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
x persons (X% of total A) earned >$200,000 (X% of total B)
x persons (X% of total A) earned >$100,000 (X% of total B)
x persons (X% of total A) earned >$50,000 (X% of total B)
x persons (X% of total A) earned >$25,000 (X% of total B)
x persons (X% of total A) earned >$12,000 (X% of total B)
x persons (X% of total A) earned >$5,000 (X% of total B)
x persons (X% of total A) earned >$1,000 (X% of total B)
x person
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
(X% of total A) earned $zero
x persons (X% of total A) made a loss
Where total A = the total number of people who were registered as recruits in that 12-month period, and where total B = the sum total of all net distributions from product sales and recruitment in that 12-month period. This information must also be provided graphically via a chart.
3 We desist from making promises or assertions that members will e
x persons (X% of total A) made a loss
Where total A = the total number of people who were registered as recruits in that 12-month period, and where total B = the sum total of all net distributions from product sales and recruitment in that 12-month period. This information must also be provided graphically via a chart.
3 We desist from making promises or assertions that members will e
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
rn any particular income and we do not promote our MLM company as a way for people to make money quickly. We do not use images of wealth which are unrepresentative of the majority of consultant earnings (as per the table above) in order to attract new recruits.
4 We offer only those products which objective research verifies as beneficial. We will not involve ourselves with products or services which are based on fa
4 We offer only those products which objective research verifies as beneficial. We will not involve ourselves with products or services which are based on fa
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
se assertions or claims. We describe our products truthfully and accurately, and product pricing is set at a level which is acceptable to the market.
5 We do not offer products for which there is little demand, nor do we offer products in a market which is already saturated. Where we claim demand for any particular product, we provide objective 3rd party market research as evidence. When we reach a diffusion rate o
5 We do not offer products for which there is little demand, nor do we offer products in a market which is already saturated. Where we claim demand for any particular product, we provide objective 3rd party market research as evidence. When we reach a diffusion rate o
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
97% in any market, we immediately place a ban on recruitment, allowing recruitment only at attrition rate.
6 Our prime focus is on product sales, not recruitment. We understand that for any company to be sustainable it must continue to sell product, and it must not over-supply the market with consultants. For this reason, the major portion of commissions paid will always be on product sales, not recruitment. Over
6 Our prime focus is on product sales, not recruitment. We understand that for any company to be sustainable it must continue to sell product, and it must not over-supply the market with consultants. For this reason, the major portion of commissions paid will always be on product sales, not recruitment. Over
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
1% of all product payout goes to the person who directly sold the product; ie, the person who did the work. We do not pay for a reward for new recruits, because we know that this leads to unsustainable downlines. We are committed to building quality, sustainable downlines, that are successful in delivering product to the consumer, generating real value for everyone.
7 We do not make members purchase training materia
7 We do not make members purchase training materia
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
, but we may recommend they pursue business studies with organisations competent in that area.
8 If we require product purchase by new recruits, such products will made available at a discount equivalent to the commission due on that product, or at a lesser price. We do not seek to profit from those who join our business. Similarly, no commissions are paid to upline for product sales to their downline.
9
8 If we require product purchase by new recruits, such products will made available at a discount equivalent to the commission due on that product, or at a lesser price. We do not seek to profit from those who join our business. Similarly, no commissions are paid to upline for product sales to their downline.
9
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
e do not require recruits to purchase product if we launch an untested product into the market. We will not allow our recruits to bear the brunt of product development.
10 If recruits/members are required to purchase marketing material, such material is provided at cost.
11 If we charge an entry fee to any recruit, that fee shall be no more than the market value of that particular consultancy at that time.
10 If recruits/members are required to purchase marketing material, such material is provided at cost.
11 If we charge an entry fee to any recruit, that fee shall be no more than the market value of that particular consultancy at that time.
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
Market value is determined by an objective 3rd party, such as a business valuation service, bank or other financial institution qualified to make such an assessment. We affirm that we are selling a real business, not mere hope.
12 We do not allow our recruits to promote the product or opportunity to friends or family, nor do we allow unsolicited sales activities of any kind. These activities are counter-productive
12 We do not allow our recruits to promote the product or opportunity to friends or family, nor do we allow unsolicited sales activities of any kind. These activities are counter-productive
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
o the development of a bona fide, sustainable business, and bring disrepute to our industry. We do not allow our recruits to communicate via advertising, newsletters, mail, blogs, emails, or in any form, in any way that detracts from the professionalism of our company (ie; exhortational advertising and wild claims are strictly forbidden). We do our best to ensure that any advertising by our consultants is of a high professio
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
al standard.
13 We have developed a proven strategy for product sales and recruitment, which we provide full training and support in.
14 We teach our recruits how to plan, schedule, document, track, measure, analyse and refine their marketing strategy. We actively prohibit false representation, pressure tactics, or unethical business practices. We promote fair and honest dealings with customers and downline
13 We have developed a proven strategy for product sales and recruitment, which we provide full training and support in.
14 We teach our recruits how to plan, schedule, document, track, measure, analyse and refine their marketing strategy. We actively prohibit false representation, pressure tactics, or unethical business practices. We promote fair and honest dealings with customers and downline
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
at all times.
15 We treat our recruits with respect at all times, and encourage an environment of learning, co-operation, and kindness. We do not tolerate sexism, racism, ageism, or homophobia and we have written protocols in place to protect all personnel, consultants, and customers from such abuse.
16 We require our consultants to display honesty at all times, and to totally refrain from exaggeration or d
15 We treat our recruits with respect at all times, and encourage an environment of learning, co-operation, and kindness. We do not tolerate sexism, racism, ageism, or homophobia and we have written protocols in place to protect all personnel, consultants, and customers from such abuse.
16 We require our consultants to display honesty at all times, and to totally refrain from exaggeration or d
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ception of any kind in their dealings with customers and with each other. We expressly forbid our consultants to sell or recruit by stealth. Our reputation is of vital importance and we rely on our consultants to present an image of which we can be proud.
17 We respond to complaints promptly, fairly, and respectfully and fully co-operate with all authorities in the event of legal disputes.
18 If and when a
17 We respond to complaints promptly, fairly, and respectfully and fully co-operate with all authorities in the event of legal disputes.
18 If and when a
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
onsultant decides to leave our company, we will refrain from blame, will seek not to disadvantage, punish or harm that person in any way, will be respectful of his/her choice and do our utmost to end our association on the best possible terms.
19 This code, along with a statement testifying our commitment to it, is displayed prominently on our web site and is contained in the information pack given to recruits/members
19 This code, along with a statement testifying our commitment to it, is displayed prominently on our web site and is contained in the information pack given to recruits/members
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/18684/diggit-MLM-Code-of-Ethics.html">MLM Code of Ethics</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/18684/diggit-MLM-Code-of-Ethics.html]MLM Code of Ethics[/url]
Related Articles:
The Important Function of Shrink Wrap for Boats
Hurricanes and Corporate Branding
Bookmark it:
|